Cincinnati Children's Blog
  • Y&H Podcast
  • Newsletter Subscribe
  • CincinnatiChildrens.org
  • Contact Us
  • Blog
  • Healthy Living
  • Rare and Complex Conditions
  • Safety and Prevention
  • Heart Conditions
  • Learning and Growing
  • Research and Discoveries
  • Blog
  • Healthy Living
  • Rare and Complex Conditions
  • Safety and Prevention
  • Heart Conditions
  • Learning and Growing
  • Research and Discoveries
  • Y&H Podcast
  • Newsletter Subscribe
  • CincinnatiChildrens.org
  • Contact Us
HOME/Cancer and Blood Diseases/Langerhans Cell Histiocytosis: Dabrafenib A Game Changer For My Son

Langerhans Cell Histiocytosis: Dabrafenib A Game Changer For My Son

Langerhans Cell Histiocytosis: Dabrafenib A Game Changer For My Son
March 6, 2019
Rebecca Mauldin
1 Comments

“What’s this rash,” I asked our local pediatrician in Oklahoma as he was finishing my son Jonathan’s two-month check-up. There were a few small, scaly bumps on his back that wouldn’t go away. It looked odd, but babies get rashes so I was expecting it would be a simple answer.

Instead, it was the start of a tortuous journey that would include chemotherapy and traveling almost 900 miles for a life-saving liver transplant.

Diagnosis: Langerhans Cell Histiocytosis

His doctor referred Jonathan to a dermatologist, who wanted to biopsy the rash to rule out a very rare disease called Langerhans cell histiocytosis, known as LCH for short. To everyone’s surprise, it came back positive. In infants like Jonathan, LCH is usually either a harmless skin rash that goes away or a potentially life-threatening disease that causes lesions in internal organs and requires chemotherapy. We were relieved to find out that further tests showed the LCH was only in his skin. However, he would need close monitoring to make sure it did not show up anywhere else.

Shortly before his first birthday, we found out that the LCH had spread to his bones, liver and spleen. Without chemotherapy, the LCH would cause more damage to these organs and be fatal. Over the next few weeks, the LCH took off aggressively. The chemotherapy wasn’t working and he was getting very sick with daily fevers. His doctors switched him to a stronger chemotherapy. Despite the harsher side effects, we could see it working on the scans. We were finally getting ahead of this beast!

Complications with the Chemotherapy

We did not celebrate for long. The next week, Jonathan was hospitalized because of a severe complication. His liver had been damaged by the LCH and now the chemotherapy was causing more damage. After consulting with several doctors, including Dr. Kumar at Cincinnati Children’s, his doctors decided to switch Jonathan to newer oral targeted therapy called dabrafenib that would more precisely target the gene mutation that was driving the LCH. The next scan showed no sign of LCH. While this was great news, there was still uncertainty on how his liver would hold up over time.

In early 2018, we learned that Jonathan’s damaged liver had caused swollen veins to develop in his esophagus and stomach that were at risk for bleeding. If they bled, it could be catastrophic. He would need a liver transplant. We were referred to a children’s hospital in Texas to complete a transplant evaluation. Several weeks later, we were told that he was denied a liver transplant because of the LCH. It was devastating news.

Jonathan Gets A New Liver

His doctors immediately recommended that we get a second opinion at Cincinnati Children’s. There, we met with Dr. Adam Nelson with the LCH team and Dr. Alex Miethke with the liver team. When we returned back to Oklahoma, Jonathan’s liver started to deteriorate faster than anyone anticipated. He had two bleeds a few weeks apart. During the last bleed, he lost a significant amount of blood and required substantial blood transfusions. He was placed in the pediatric intensive care unit to manage the bleeding. When he was stable enough to transport, he was flown from Oklahoma to Cincinnati Children’s to await a liver transplant. On July 11, 2018, Jonathan went into surgery to receive a new liver. We are incredibly appreciative of the donor family who gave him the gift of life.

It has been seven months since the liver transplant and Jonathan is doing terrific. The transformation has been dramatic. Before the transplant, he had difficulty walking because of how large and damaged his liver had become. Now, he is running and playing with ease. After over a year with a feeding tube, he is back to eating on his own. His skin and eyes no longer have a yellow tint. He is full of life and energy.

Jonathan’s New Regimen

Jonathan continues to take dabrafenib for the LCH and anti-rejection medicine for the liver transplant, but otherwise is a normal two and a half year old boy. Prior to a few years ago, children who had chemotherapy-resistant LCH had to endure more intensive treatments with higher toxicities or suffer further damage from the LCH, both of which could be fatal.

The discovery of the BRAF gene mutation in over half of LCH tumors and the development of drugs which target this same mutation have been revolutionary in the treatment of this very high risk group. By taking a medicine at home, children have had their aggressive LCH go into remission with no or minimal side effects. Jonathan’s situation was further complicated by the critical need for a liver transplant. Cincinnati Children’s research and experience with using dabrafenib for LCH was a game changer that allowed Jonathan to receive a life-saving liver transplant.

We are incredibly appreciative of the excellent care Jonathan has received. He had a wonderful group of doctors and supporting staff who genuinely care about him and have helped him get back to being our silly boy with deep belly laughs and huge smile.

To learn more about our Langerhans Cell Histiocytosis Center, please call 513-517-CBDI or email us at lch@cchmc.org.

Related Articles

From My Perspective: A Doctor’s View of Multidisciplinary Care
From My Perspective: A Doctor’s View of Multidisciplinary Care
Liver Transplant Recipient Becomes Nurse on Same Floor
Liver Transplant Recipient Becomes Nurse on Same Floor
Giving the Gift of Life Twice: Living-Related Donor Transplant
Giving the Gift of Life Twice: Living-Related Donor Transplant
Liver Transplant Recipient Pursues Dream of Becoming A Pediatric Gastroenterologist
Liver Transplant Recipient Pursues Dream of Becoming A Pediatric Gastroenterologist
TAGS:
  • Langerhans cell histiocytosis
  • liver transplant

About the author: Rebecca Mauldin

Rebecca Mauldin is a wife and mom of three from Edmond, Oklahoma. She enjoys cooking, running and spreadsheets. She works for the Federal Aviation Administration as an industrial engineer analyzing and improving complex systems and processes.

Write A Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comments

Jill Jackson May 10, 2025 at 8:11 pm

Hi Rebecca! What a story. I hope, I pray, your children and entire family are doing wonderfully, and that LCH remains wrestled down.

I grew up in Tulsa, K-12+. In recent years, I have seen that over 30 years of symptoms might be Histiocytosis. I’ve been working with a PCP to get the proof that the Histiocytosis clinic needs. I’m hoping that some studies get evaluated by the specialty clinic. People who haven’t seen it seem bound to not recognize it!

I may one day live in Tulsa again. I’m hoping to get firm diagnoses before going anywhere else. It might take leaving though to get the right evaluation.

I’m IMPRESSED over how BLESSED you and your first physicians were to even think of LCH. I mean, at 2 months of age and such a mild looking rash!!!!

The lovely radiance on your son’s back (in wound area) looks like most of my skin. Pretty. Dangerous. Pretty Dangerous.

What a rare condition that I’m writing the first comment at long last! More proof of the miraculous “suspicion” so early on. Wow.

I’m grateful for your summary of what I know had to be intensely challenging. I’m also grateful to you and your son & whole family for sharing the images and your writing time to help me (& maybe Mayo doctors!) diagnose, treat, and protect my body ASAP.

God bless you.

Jill

Topics

  • Cancer and Blood Diseases
  • Child Development and Behavior
  • Childhood Obesity
  • Chronic Care Networks
  • Cincinnati Walks for Kids
  • Featured Faces
  • Fetal Conditions
  • Fitness and Nutrition
  • Food Allergies
  • Ghana 2012
  • Health Care Public Policy
  • Health Care Quality
  • Health Care Reform
  • Healthy Living
  • Heart Conditions
  • Hospital Operations
  • Learning and Growing
  • Nurses Week 2012
  • Patient Family Experience
  • Patient Flow
  • Patient Safety
  • Pin of the Week
  • Rare and Complex Conditions
  • Research and Discoveries
  • Safety and Prevention
  • Share Your Story
  • Technology
  • The Young & Healthy Podcast
  • Uncategorized
  • Vaccines
  • Volunteerism
  • What's New
See All Topics
See Less Topics

Subscribe

Subscribe today to our family newsletter for tips, blog posts, podcasts and more.

Subscribe Now

Popular Posts

  • 6 Questions to Ask When Your Child Complains of Chest Pain 1.1k views

  • Lean, Purple Drank, Sizzurp: A Dangerous Teenage Drink 642 views

  • Stuttering In Young Kids: When To Be Concerned 621 views

  • Family Finds Heart Care Needed for Complex Condition 507 views

  • How To Increase Calories In Your Underweight Child’s Diet 268 views

  • Tips for Helping Babies Transition to Cow’s Milk 254 views

About

The Cincinnati Children’s blog features thoughts and perspectives from our experts on all things pediatric health. This blog does not provide medical advice, diagnosis, or treatment. Learn More »

Contact Us
  • 3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
  • 1-513-636-4200 | 1-800-344-2462
  • TTY: 1-513-636-4900
  • socialmedia@cchmc.org
Connect With Us
  • Newsletter Subscribe
  • CincinnatiChildrens.org
  • Contact Us

© 2009-2022 Cincinnati Children’s Hospital Medical Center